Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates

Century Therapeutics, Inc. (IPSC) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of a loss of$ 0.31 per share. This compares to loss of $0.45 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 387.10%. A quarter ago, it was expected that this company would post a loss of$ 0.45 per share when it actually produced a loss of $0.43, delivering a surprise of 4.44%.Over the last four quarters, ...